1. The clinical role of glycobiology on ovarian cancer progression Rhyisa Armbrister, Laura Ochoa, and Karen L. Abbott 2. Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach Yehia Mechref, Wenjing Peng, Sakshi Gautam, Parisa Ahmadi, Yu Lin, Jianhui Zhu, Jie Zhang, Suyu Liu, Amit G. Singal, Neehar D. Parikh, and David M. Lubman 3. Beyond glyco-proteomics-Understanding the role of genetics in cancer biomarkers Andrew DelaCourt, and Anand Mehta 4. Measuring the multifaceted roles of mucin-domain glycoproteins in cancer Nicholas M. Riley, Ru M. Wen, Carolyn R. Bertozzi, James D. Brooks, and Sharon J. Pitteri 5. Role of tumor cell sialylation in pancreatic cancer progression Michael P. Marciel, Barnita Haldar, Jihye Hwang, Nikita Bhalerao, and Susan L. Bellis 6. The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma Norhan B.B. Mohammed, Aristotelis Antonopoulos, Anne Dell, Stuart M. Haslam, and Charles J. Dimitroff 7. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity Giang Le Minh, and Mauricio J. Reginato 8. The biology of E-selectin ligands in leukemogenesis Evan Ales, and Robert Sackstein 9. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential Hua Yang, and Lianchun Wang